288 related articles for article (PubMed ID: 17331889)
1. Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).
Gao W; Dalton JT
Drug Discov Today; 2007 Mar; 12(5-6):241-8. PubMed ID: 17331889
[TBL] [Abstract][Full Text] [Related]
2. Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?
Gao W; Dalton JT
Mol Interv; 2007 Feb; 7(1):10-3. PubMed ID: 17339601
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery.
Segal S; Narayanan R; Dalton JT
Expert Opin Investig Drugs; 2006 Apr; 15(4):377-87. PubMed ID: 16548787
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.
Gao W; Kim J; Dalton JT
Pharm Res; 2006 Aug; 23(8):1641-58. PubMed ID: 16841196
[TBL] [Abstract][Full Text] [Related]
5. Selective androgen receptor modulators: in pursuit of tissue-selective androgens.
Omwancha J; Brown TR
Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931
[TBL] [Abstract][Full Text] [Related]
6. Development of selective androgen receptor modulators (SARMs).
Narayanan R; Coss CC; Dalton JT
Mol Cell Endocrinol; 2018 Apr; 465():134-142. PubMed ID: 28624515
[TBL] [Abstract][Full Text] [Related]
7. Selective androgen receptor modulators in drug discovery: medicinal chemistry and therapeutic potential.
Cadilla R; Turnbull P
Curr Top Med Chem; 2006; 6(3):245-70. PubMed ID: 16515480
[TBL] [Abstract][Full Text] [Related]
8. Selective androgen receptor modulators as function promoting therapies.
Bhasin S; Jasuja R
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):232-40. PubMed ID: 19357508
[TBL] [Abstract][Full Text] [Related]
9. Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.
Narayanan R; Coss CC; Yepuru M; Kearbey JD; Miller DD; Dalton JT
Mol Endocrinol; 2008 Nov; 22(11):2448-65. PubMed ID: 18801930
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the development of selective androgen receptor modulators.
Zhang X; Lanter JC; Sui Z
Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
[TBL] [Abstract][Full Text] [Related]
11. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.
Choi SM; Lee BM
Expert Opin Drug Saf; 2015; 14(11):1773-85. PubMed ID: 26401842
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
13. Development of selective androgen receptor modulators and their therapeutic applications.
Chen F; Rodan GA; Schmidt A
Zhonghua Nan Ke Xue; 2002; 8(3):162-8. PubMed ID: 12478835
[TBL] [Abstract][Full Text] [Related]
14. [A potential of selective androgen receptor modulator(SARM)for the therapy of osteoporosis].
Yanase T
Clin Calcium; 2016 Jul; 26(7):1023-30. PubMed ID: 27346314
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator.
Vajda EG; López FJ; Rix P; Hill R; Chen Y; Lee KJ; O'Brien Z; Chang WY; Meglasson MD; Lee YH
J Pharmacol Exp Ther; 2009 Feb; 328(2):663-70. PubMed ID: 19017848
[TBL] [Abstract][Full Text] [Related]
16. Overview of the development of selective androgen receptor modulators (SARMs) as pharmacological treatment for osteoporosis (1998-2021).
Xie Y; Tian Y; Zhang Y; Zhang Z; Chen R; Li M; Tang J; Bian J; Li Z; Xu X
Eur J Med Chem; 2022 Feb; 230():114119. PubMed ID: 35063736
[TBL] [Abstract][Full Text] [Related]
17. A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats.
Allan G; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Ng R; Sui Z; Lundeen S
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):207-13. PubMed ID: 18502117
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal selective androgen receptors modulators (SARMs): designer androgens with flexible structures provide clinical promise.
Brown TR
Endocrinology; 2004 Dec; 145(12):5417-9. PubMed ID: 15545403
[No Abstract] [Full Text] [Related]
19. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
Dalton JT; Taylor RP; Mohler ML; Steiner MS
Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
[TBL] [Abstract][Full Text] [Related]
20. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.
Solomon ZJ; Mirabal JR; Mazur DJ; Kohn TP; Lipshultz LI; Pastuszak AW
Sex Med Rev; 2019 Jan; 7(1):84-94. PubMed ID: 30503797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
